HEALTH

  • 563
  • 536

Switching to real-time CGM beneficial for patients with type 1 diabetes: ALERTT1 trial - Medical Dialogues

Belgium: Findings from a 24-month ALERTT1 trial support real-time continuous glucose monitoring (rtCGM) in caring for adults with type 1 diabetes (T1D).The study, featured in The Lancet Diabetes...

image

Ads

Video News

Hot News

Ads

News Letter

Your email address will not be this published. Required fields are News Today.